nutrients-logo

Journal Browser

Journal Browser

Food as Medicine for Brain and Other Tissues

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Nutrition and Public Health".

Deadline for manuscript submissions: 15 May 2026 | Viewed by 814

Special Issue Editors


E-Mail Website
Guest Editor
Department of Food Science and Nutrition, University of Florida, Gainesville, FL 32611, USA
Interests: precision ketogenic therapy; food as precision medicine; nutritional biochemistry; carnitine function and metabolism; pig model for human metabolism

E-Mail Website
Guest Editor
Department of Pediatrics, Division of Neurology, University of Florida, Gainesville, FL 32610, USA
Interests: precision ketogenic therapy; adrenoleukodystrophy; epilepsy in children; metachromatic leukodystrophy; tuberous sclerosis

Special Issue Information

Dear Colleagues,

Food to treat and prevent disease has been practiced for millennia in most of the world’s cultures. “Let thy food be thy medicine and medicine be thy food” is a quote often attributed to the ancient Greek philosopher Hippocrates (400 BC). A century ago, the first papers describing the ketogenic diet as a dietary therapy for epilepsy were published. Many versions of the ketogenic diet designed to prevent and treat seizures and symptoms other than seizures have been published with the assumed mechanism of supplying ketones as an alternate fuel for glucose. The current literature documents many metabolic functions of ketone bodies in addition to being a fuel source. Thus, the mechanism of ketogenic therapy is much more than the supply of an alternate fuel. As with other nutrients, the use of a nutrient in food as medicine has led some investigators to use direct administration of the ketone body nutrient as a chemical drug. Brain tissue is very sensitive to nutrient availability from in utero throughout the lifespan. Brain tissue is also very sensitive to the metabolic products of other tissues comprising the body’s metabolic web.

The objective of this proposed Special Issue on “Food as Medicine for the Brain and Other Tissues” is to publish selected papers studying the clinical role of food containing a complex chemical matrix to prevent and treat neurological symptoms using today’s precision medicine approach and papers investigating the metabolic mechanism of the physiological role of food in maintaining or returning metabolic homeostasis to normal. Papers documenting the role of food intake on the efficacy of other currently used medical therapies and the role of food intake on the metabolism of organs throughout the body that affect brain function are welcome.

Dr. Peggy R. Borum
Dr. Steven Parrish Winesett
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • dietary therapies for epilepsy
  • ketogenic diet
  • food is medicine
  • food as precision medicine
  • brain metabolism of macronutrients

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

13 pages, 405 KiB  
Article
Role of the Ketogenic Diet Therapy and ACTH as Second Treatments in Drug-Resistant Infantile Epileptic Spasms Syndrome
by Anastasia Dressler, Letizia Bonfanti, Petra Trimmel-Schwahofer, Barbara Porsche, Simona Bertoli and Christoph Male
Nutrients 2025, 17(13), 2085; https://doi.org/10.3390/nu17132085 - 23 Jun 2025
Viewed by 442
Abstract
Objectives: The aim of this study was to evaluate the effectiveness of sequential treatments with adrenocorticotropic hormone (ACTH) or ketogenic diet therapy (KDT) in infants with infantile epileptic spasms syndrome (IESS) who did not achieve seizure freedom after initial treatment with either [...] Read more.
Objectives: The aim of this study was to evaluate the effectiveness of sequential treatments with adrenocorticotropic hormone (ACTH) or ketogenic diet therapy (KDT) in infants with infantile epileptic spasms syndrome (IESS) who did not achieve seizure freedom after initial treatment with either KDT or ACTH. Methods: We conducted a cohort study following a parallel-cohort randomized controlled trial comparing KDT with ACTH as first-line treatment for IESS. Infants who failed to respond were switched per protocol to the alternative treatment (ACTH or KDT) or, if this was not feasible or unsuccessful, to anti-seizure medications (ASMs). The primary outcome was the frequency of sustained seizure freedom at last follow-up. Results: Of 101 infants allocated to the initial treatment phase, N = 67 required further treatment. Of these, 31% (21/67) achieved sustained seizure freedom after the second treatment phase, and 15% (7/46) after rescue treatment with ASMs. KDT as the second treatment achieved sustained seizure freedom in 50% (12/24), compared to 19% (3/16) with ACTH and 9% (2/22) with ASMs. The cumulative response rate after the first and second treatments was 64% for the KDT-ACTH sequence and 68% for the ACTH-KDT sequence. The cumulative response after all three treatment phases was 78% (KDT-ACTH-ASM) and 72% (ACTH-KDT-ASM), respectively. Conclusions: KDT is at least as effective as ACTH as a second treatment and significantly more effective than ASMs in achieving sustained seizure freedom in infants with IESS. Full article
(This article belongs to the Special Issue Food as Medicine for Brain and Other Tissues)
Show Figures

Figure 1

Back to TopTop